Tag: Lars
CEO Lars Fruergaard Jorgensen discusses Wegovy
It's been a rocky few months for Novo Nordisk.Prescription data from IQVIA suggests Novo's obesity drug Wegovy is losing ground to rival Zepbound from [...]
Foreign exchange Weekly Look Again: CLS reviews a rise in March buying and selling volumes, Lars Gottwik leaves JFD – Leaprate Foreign exchange Buying and selling Information
Foreign exchange Weekly Look Again: CLS reviews a rise in March buying and selling volumes, Lars Gottwik leaves JFD Leaprate Foreign exc [...]
2 / 2 POSTS